Alnylam Seeking Lumasiran Approvals Soon, But Has Two Rivals On Its Heels

 
• By Mandy Jackson
  
Kidney
Primary hyperoxaluria type 1 causes kidney stones and renal disease. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D